EUVIMEDEUVIMED entdecken
Crossref

Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa?

Carlo Alberto Maronese iD, John R Ingram iD, Angelo V Marzano iD

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljad224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Carlo Alberto Maronese und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Biological Products. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the landscape for hidradenitis suppurativa (HS) medical treatment is rapidly expanding, seemingly taking the same steps that marked the evolution of psoriasis management, upcoming agents still do not appear to offer complete disease control. Better control of severe cases of HS refractory to biologic monotherapy may require investigation of pathogenesis-driven, combination regimens sooner rather than later.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaBiological ProductsHumansAdalimumabInfliximabDrug Combinations

Substanzen

AdalimumabInfliximabDrug CombinationsBiological Products

Autor:innen und Institutionen

  • Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Division of Infection and Immunity, Cardiff University, Cardiff, UK.

ORCID-Profile: Carlo Alberto Maronese, John R Ingram, Angelo V Marzano

Zitieren

APA

Maronese, C. A., Ingram, J. R., & Marzano, A. V. (2023). Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa?. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad224

Vancouver

Maronese CA, Ingram JR, Marzano AV. Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa?. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad224

BibTeX
@article{Maronese2023,
  author = {Maronese, Carlo Alberto and Ingram, John R and Marzano, Angelo V},
  title = {Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa?},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljad224}
}
Kostenlos starten →